Related references
Note: Only part of the references are listed.Antitumor Activity of Ohmyungsamycin A through the Regulation of the Skp2-p27 Axis and MCM4 in Human Colorectal Cancer Cells
Woong Sub Byun et al.
JOURNAL OF NATURAL PRODUCTS (2020)
A novel small molecule STAT3 inhibitor SLSI-1216 suppresses proliferation and tumor growth of triple-negative breast cancer cells through apoptotic induction
Soo Kyung Park et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Antiproliferative and Antimigration Activities of Fluoro-Neplanocin A via Inhibition of Histone H3 Methylation in Triple-Negative Breast Cancer
Woong Sub Byun et al.
BIOMOLECULES (2020)
Targeting Histone Methyltransferase DOT1L by a Novel Psammaplin A Analog Inhibits Growth and Metastasis of Triple-Negative Breast Cancer
Woong Sub Byun et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Esculetin suppresses tumor growth and metastasis by targeting Axin2/E-cadherin axis in colorectal cancer
Won Kyung Kim et al.
BIOCHEMICAL PHARMACOLOGY (2018)
A novel selenonucleoside suppresses tumor growth by targeting Skp2 degradation in paclitaxel-resistant prostate cancer
Woong Sub Byun et al.
BIOCHEMICAL PHARMACOLOGY (2018)
N6-Substituted 5'-N-Methylcarbamoyl-4'-selenoadenosines as Potent and Selective A3 Adenosine Receptor Agonists with Unusual Sugar Puckering and Nucleobase Orientation
Jinha Yu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Polypharmacology of N6-(3-lodobenzyl)adenosine-5′-N-methyluronamide (IB-MECA) and Related A3 Adenosine Receptor Ligands: Peroxisome Proliferator Activated Receptor (PPAR) γ Partial Agonist and PPARδ Antagonist Activity Suggests Their Antidiabetic Potential
Jinha Yu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Discovery of Novel Disruptor of Silencing Telomeric 1-Like (DOTI L) Inhibitors using a Target-Specific Scoring Function for the (S)-Adenosyl-L-methionine (SAM)-Dependent Methyltransferase Family
Yulan Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Mechanisms of Pinometostat (EPZ-5676) Treatment-Emergent Resistance in MLL-Rearranged Leukemia
Carly T. Campbell et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Synthesis of Acyclic Selenonucleoside Phosphonates as Potential Antiviral Agents
Pramod K. Sahu et al.
ASIAN JOURNAL OF ORGANIC CHEMISTRY (2016)
Dysregulation of histone methyltransferases in breast cancer - Opportunities for new targeted therapies?
Ewa M. Michalak et al.
MOLECULAR ONCOLOGY (2016)
Efficient synthesis and biological activity of Psammaplin A and its analogues as antitumor agents
Suckchang Hong et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Selenoacyclovir and Selenoganciclovir: Discovery of a New Template for Antiviral Agents
Pramod K. Sahu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
DOT1L cooperates with the c-Myc-p300 complex to epigenetically derepress CDH1 transcription factors in breast cancer progression
Min-Hyung Cho et al.
NATURE COMMUNICATIONS (2015)
DOT1L: a new therapeutic target for aggressive breast cancer
Jeong-Yeon Lee et al.
ONCOTARGET (2015)
Inhibition of histone H3K79 methylation selectively inhibits proliferation, self-renewal and metastatic potential of breast cancer
Li Zhang et al.
ONCOTARGET (2014)
A Medicinal Chemistry Perspective for Targeting Histone H3 Lysine-79 Methyltransferase DOT1 L
Justin L. Anglin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Synthesis and Structure-Activity Relationship Investigation of Adenosine-Containing Inhibitors of Histone Methyltransferase DOT1L
Justin L. Anglin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Efficient synthetic method of Psammaplin A
Suckchang Hong et al.
TETRAHEDRON LETTERS (2012)
DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis
Anh Tram Nguyen et al.
BLOOD (2011)
Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
Scott R. Daigle et al.
CANCER CELL (2011)
MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L
Kathrin M. Bernt et al.
CANCER CELL (2011)
The diverse functions of Dot1 and H3K79 methylation
Anh Tram Nguyen et al.
GENES & DEVELOPMENT (2011)
Selective Inhibitors of Histone Methyltransferase DOT1L: Design, Synthesis, and Crystallographic Studies
Yuan Yao et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Relative Abundance of Selenoprotein P Isoforms in Human Plasma Depends on Genotype, Se Intake, and Cancer Status
Catherine Meplan et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells
Mee Young Ahn et al.
GYNECOLOGIC ONCOLOGY (2008)
Selenium compounds and apoptotic modulation:: A new perspective in cancer therapy
Carmen Sanmartin et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2008)
Bioassay for the identification of natural product-based activators of peroxisome proliferator-activated receptor-γ (PPAR-γ):: The marine sponge metabolite psammaplin A activates PPARγ and induces apoptosis in human breast tumor cells
FD Mora et al.
JOURNAL OF NATURAL PRODUCTS (2006)
Sulforhodamine B colorimetric assay for cytotoxicity screening
Vanicha Vichai et al.
NATURE PROTOCOLS (2006)
Psammaplins from the sponge Pseudoceratina purpurea:: Inhibition of both histone deacetylase and DNA methyltransferase
IC Piña et al.
JOURNAL OF ORGANIC CHEMISTRY (2003)
New bromotyrosine metabolites from the sponge Aplysinella rhax
J Shin et al.
TETRAHEDRON (2000)
Share Paper
